Sihe Zhang

1.3k total citations
49 papers, 913 citations indexed

About

Sihe Zhang is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Sihe Zhang has authored 49 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 10 papers in Cell Biology and 10 papers in Cancer Research. Recurrent topics in Sihe Zhang's work include RNA Interference and Gene Delivery (8 papers), Endoplasmic Reticulum Stress and Disease (7 papers) and Cellular transport and secretion (7 papers). Sihe Zhang is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Endoplasmic Reticulum Stress and Disease (7 papers) and Cellular transport and secretion (7 papers). Sihe Zhang collaborates with scholars based in China, United States and Sweden. Sihe Zhang's co-authors include Zhi‐Nan Chen, Jian‐Li Jiang, Mattias Belting, Pu Zhao, Anders Wittrup, Qing Zhang, Wei Zhang, Juan Tang, Huijie Bian and Xiaoling Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Sihe Zhang

46 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sihe Zhang China 16 636 182 158 152 134 49 913
Liubov Zaritskaya United States 14 487 0.8× 273 1.5× 240 1.5× 310 2.0× 72 0.5× 18 1.1k
Tuhina Mazumdar United States 17 398 0.6× 143 0.8× 106 0.7× 232 1.5× 71 0.5× 32 785
Romi Gupta United States 19 650 1.0× 134 0.7× 185 1.2× 215 1.4× 57 0.4× 50 945
Sumit Agarwal United States 21 721 1.1× 152 0.8× 255 1.6× 242 1.6× 74 0.6× 40 969
Eugene Dempsey Ireland 15 318 0.5× 163 0.9× 119 0.8× 79 0.5× 40 0.3× 24 686
Yunping Lu China 18 762 1.2× 125 0.7× 324 2.1× 287 1.9× 125 0.9× 77 1.1k
Zhenghu Chen United States 18 754 1.2× 159 0.9× 161 1.0× 262 1.7× 83 0.6× 33 988
Matthew W. VanBrocklin United States 15 617 1.0× 190 1.0× 126 0.8× 275 1.8× 81 0.6× 32 1.1k

Countries citing papers authored by Sihe Zhang

Since Specialization
Citations

This map shows the geographic impact of Sihe Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sihe Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sihe Zhang more than expected).

Fields of papers citing papers by Sihe Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sihe Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sihe Zhang. The network helps show where Sihe Zhang may publish in the future.

Co-authorship network of co-authors of Sihe Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Sihe Zhang. A scholar is included among the top collaborators of Sihe Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sihe Zhang. Sihe Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Shiwu, Zhenglu Wang, Yuan Guo, et al.. (2025). The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond. Drug Resistance Updates. 79. 101209–101209. 7 indexed citations
2.
Zhang, Sihe, et al.. (2025). Gelatin Zymography: Principle, Method and Application in Cancer Research. Methods in molecular biology. 2917. 3–10.
3.
Wang, Yang, et al.. (2024). RAB42 overexpression correlates with poor prognosis, immune cell infiltration and chemoresistance. Frontiers in Pharmacology. 15. 1445170–1445170. 3 indexed citations
4.
Wang, Bo, et al.. (2024). Antibody drugs targeting SARS-CoV-2: Time for a rethink?. Biomedicine & Pharmacotherapy. 176. 116900–116900. 4 indexed citations
5.
Wang, Bo, Yang Wang, Ping Chen, et al.. (2024). Hypoxia‐activated ADCC‐enhanced humanized anti‐CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity. SHILAP Revista de lepidopterología. 5(3). e512–e512. 6 indexed citations
6.
Wang, Chenhui, Bo Wang, Qing Zhang, & Sihe Zhang. (2024). Tumor microenvironment-responsive cell-penetrating peptides: Design principle and precision delivery. Colloids and Surfaces B Biointerfaces. 242. 114100–114100. 6 indexed citations
7.
Sun, Zhe, Jinhai Huang, Zvi Fishelson, Chenhui Wang, & Sihe Zhang. (2023). Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress. Biomedicines. 11(7). 1971–1971. 37 indexed citations
8.
Zhang, Qiangzhe, Xicheng Liu, Zhi‐Nan Chen, & Sihe Zhang. (2022). Novel GIRlncRNA Signature for Predicting the Clinical Outcome and Therapeutic Response in NSCLC. Frontiers in Pharmacology. 13. 937531–937531. 5 indexed citations
9.
Sun, Zhe, Jinhai Huang, Jing Li, et al.. (2021). Arf6-mediated macropinocytosis-enhanced suicide gene therapy of C16TAB-condensed Tat/pDNA nanoparticles in ovarian cancer. Nanoscale. 13(34). 14538–14551. 10 indexed citations
10.
Zhang, Qing, Li Ding, Changsen Bai, et al.. (2021). A TTP-incorporated scoring model for predicting mortality of solid tumor patients with bloodstream infection caused by Escherichia coli. Supportive Care in Cancer. 30(1). 413–421. 1 indexed citations
11.
Qi, Shanshan, Jing Li, Pu Zhao, et al.. (2019). YIPF2 is a novel Rab-GDF that enhances HCC malignant phenotypes by facilitating CD147 endocytic recycle. Cell Death and Disease. 10(6). 462–462. 23 indexed citations
12.
Zhang, Qing, Li Ding, Zheng Li, et al.. (2019). <p>Clinical outcome of <em>Escherichia coli</em> bloodstream infection in cancer patients with/without biofilm formation: a single-center retrospective study</p>. Infection and Drug Resistance. Volume 12. 359–371. 20 indexed citations
13.
Qi, Shanshan, et al.. (2018). GRP75 modulates oncogenic Dbl-driven endocytosis derailed via the CHIP-mediated ubiquitin degradation pathway. Cell Death and Disease. 9(10). 971–971. 16 indexed citations
14.
Gao, Zhihui, Shanshan Qi, Nan Yang, et al.. (2018). Macropinocytosis activated by oncogenic Dbl enables specific targeted delivery of Tat/pDNA nano-complexes into ovarian cancer cells. International Journal of Nanomedicine. Volume 13. 4895–4911. 17 indexed citations
15.
Wang, Ming, Daohui Lin, Sihe Zhang, et al.. (2012). Prokaryotic expression of the truncated duck enteritis virus UL27 gene and characteristics of UL27 gene and its truncated product. Acta Virologica. 56(4). 323–328. 4 indexed citations
16.
Kong, Ling‐Min, Cheng‐Gong Liao, Liang Chen, et al.. (2010). Promoter hypomethylation up‐regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 15(6). 1415–1428. 53 indexed citations
17.
Wittrup, Anders, Sihe Zhang, Gerdy B. ten Dam, et al.. (2009). ScFv Antibody-induced Translocation of Cell-surface Heparan Sulfate Proteoglycan to Endocytic Vesicles. Journal of Biological Chemistry. 284(47). 32959–32967. 51 indexed citations
18.
Zhao, Pu, Wei Zhang, Juan Tang, et al.. (2009). Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Science. 101(2). 387–395. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026